Literature DB >> 35978205

Myostatin deficiency decreases cardiac extracellular matrix in pigs.

Hyo-Jin Paek1,2, Biao-Hu Quan1,2, Hak-Myong Choe2, Zhou-Yan Li2, Xi-Jun Yin3,4.   

Abstract

Myostatin (MSTN), a member of the TGF-β superfamily, negatively regulates muscle growth. MSTN inhibition has been known to cause a double-muscled phenotype in skeletal muscle and fibrosis reduction in the heart. However, the role of MSTN in the cardiac extracellular matrix (ECM) needs more studies in various species of animal models to draw more objective conclusions. The main objective of the present study was to investigate whether loss of MSTN affects the cardiac extracellular matrix in pigs. Three MSTN knockouts (MSTN-/-) and three wild type (WT) male pigs were generated by crossing MSTN ± heterozygous gilts and boars. Cardiac ECM and underlying mechanisms were determined post-mortem. The role of MSTN on collagen expression was investigated by treating cardiac fibroblasts with active MSTN protein in vitro. MSTN protein was detected in WT hearts, while no expression was detected in MSTN-/- hearts. The heart-to-body weight ratio was significantly decreased in MSTN-/- pigs. The morphometric analyses, including picrosirius red staining, immunofluorescent staining, and ultra-structural thickness examination of the endomysium, revealed a significant reduction of connective tissue content in MSTN-/- hearts compared to WT. Hydroxyproline, type I collagen (Col1A), and p-Smad3/Smad3 levels were significantly lower in MSTN-/- hearts in vivo. On the contrary, cardiac fibroblasts treated with exogenous MSTN protein overexpressed Col1A and activated Smad and AKT signaling pathways in vitro. The present study suggests that inhibition of MSTN decreases cardiac extracellular matrix.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Extracellular matrix; Fibroblast; Heart; Myostatin

Mesh:

Substances:

Year:  2022        PMID: 35978205     DOI: 10.1007/s11248-022-00322-w

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   3.145


  29 in total

Review 1.  Aging of myocardial collagen.

Authors:  R R de Souza
Journal:  Biogerontology       Date:  2002       Impact factor: 4.277

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

Review 3.  Cardiac fibroblasts: friend or foe?

Authors:  Troy A Baudino; Wayne Carver; Wayne Giles; Thomas K Borg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-14       Impact factor: 4.733

4.  Hippo-YAP and mTOR pathways collaborate to regulate organ size.

Authors:  Alfred Csibi; John Blenis
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

5.  Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts.

Authors:  Xueying Chen; Guoliang Liu; Wei Zhang; Jianing Zhang; Yugang Yan; Wenqian Dong; Ershun Liang; Yun Zhang; Mingxiang Zhang
Journal:  Int J Biochem Cell Biol       Date:  2015-10-23       Impact factor: 5.085

Review 6.  The role of inflammatory and fibrogenic pathways in heart failure associated with aging.

Authors:  Wei Chen; Nikolaos G Frangogiannis
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

7.  Inhibition of myostatin reverses muscle fibrosis through apoptosis.

Authors:  Zhao Bo Li; Jiangyang Zhang; Kathryn R Wagner
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

8.  Myostatin does not regulate cardiac hypertrophy or fibrosis.

Authors:  Ronald D Cohn; Hsin-Yueh Liang; Reena Shetty; Theodore Abraham; Kathryn R Wagner
Journal:  Neuromuscul Disord       Date:  2007-03-02       Impact factor: 4.296

9.  Myostatin regulates energy homeostasis in the heart and prevents heart failure.

Authors:  Nadine Biesemann; Luca Mendler; Astrid Wietelmann; Sven Hermann; Michael Schäfers; Marcus Krüger; Thomas Boettger; Thilo Borchardt; Thomas Braun
Journal:  Circ Res       Date:  2014-05-07       Impact factor: 17.367

Review 10.  Regeneration in heart disease-Is ECM the key?

Authors:  Ahmad F Bayomy; Michael Bauer; Yiling Qiu; Ronglih Liao
Journal:  Life Sci       Date:  2012-09-12       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.